Impact of degradation products of sulfamethoxazole on mammalian cultured cells

Environmental Toxicology

Volumn 23, Issue 4, 2008, Pages 492-498

  Yargeau, Viviane ^a   Huot, Jennifer Caitlin ^a   Rodayan, Angela ^a   Rouleau, Leonie ^a,b   Roy, Ranjan ^a   Leask, Richard L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Antibiotics; Degradation products; Mammalian cells; Ozonation; Sulfamethoxazole

Indexed keywords

ARSENIC COMPOUNDS; BODY FLUIDS; CELLS; ENVIRONMENTAL IMPACT; HEALTH; MAMMALS; NITRATES; NITROGEN COMPOUNDS; OFFSHORE OIL WELL PRODUCTION; OZONE; OZONE WATER TREATMENT; OZONIZATION; POTABLE WATER; SULFATE MINERALS; WASTE TREATMENT;

CONTROL CELLS; CULTURED CELLS; DEGRADATION PRODUCTS; DRINKING WATER; OZONATION; OZONATION TREATMENT; SULFAMETHOXAZOLE; WASTE STREAMS; WATER SAMPLES;

DEGRADATION;

ALCOHOL DERIVATIVE; DRUG METABOLITE; NITRATE; SULFAMETHOXAZOLE; SULFANILAMIDE;

ANTIBIOTICS; CYTOLOGY; DEGRADATION; MAMMAL; OZONE;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL STRUCTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG DEGRADATION; DRUG STRUCTURE; GEOMETRY; HUMAN; HUMAN CELL; MAMMAL CELL; NITROBLUE TETRAZOLIUM TEST; OZONATION; PRIORITY JOURNAL; REACTION ANALYSIS; WASTE WATER MANAGEMENT;

ANTI-BACTERIAL AGENTS; CELL LINE, TUMOR; HUMANS; MOLECULAR STRUCTURE; OXIDANTS, PHOTOCHEMICAL; OZONE; SULFAMETHOXAZOLE; TIME FACTORS; WATER POLLUTANTS, CHEMICAL; WATER PURIFICATION;

MAMMALIA;

EID: 47549105314     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20368     Document Type: Article

References (15)

1. Al-Ahmad A, Daschner FD, Kummerer K. 1999. Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of waste water bacteria. Arch Environ Contam Toxicol 37:158-163.
2. Andreozzi R, Raffaele M, Nicklas P. 2003. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319-1330.
3. Boreen AL, Arnold WA, McNeill K. 2004. Photochemical fate of sulfa drugs in then aquatic environment: Sulfa drugs containing five-membered heterocyclic groups. Environ Sci Technol 38:3933-3940.
4. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect Suppl 107(S6):S907-S938.
5. Dodd MC, Huang C-H. 2004. Transformation of the antibacterial agent sulfamethoxazole in reactions with chlorine: Kinetics, mechanisms, and pathways. Environ Sci Technol 38:5607-5615.
6. Heberer T. 2002. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicol Lett 131:5-17.
7. Hirsch R, Ternes T, Haberer K, Kratz K-L. 1999. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109-118.
8. Ikehata K, Naghashkar NJ, El-Din MG. 2006. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: A review ozone. Sci Eng 28:353-414.
9. Kielhofner G. 2005. Rethinking disability and what to do about it: Disability studies and its implications for occupational therapy. Am J Occup Ther 59:487-496.
10. Kummerer K. 2003. Significance of antibiotics in the environment. J Antimicrob Chemother 52:5-7.
11. Laville N, Aït-Aïssa S, Gomez E, Casellas C, Percher JM. 2004. Effects of human pharmaceuticals on cytotoxicity. EROD activity and ROS production in fish hepatocytes [Electronic Version]. Toxicology 196:41-55.
12. Lindberg R, Jarnheimer P-A, Olsen B, Johansson M, Tysklind M. 2004. Determination of antibiotic substances in hospital sewage water using solid phase extraction and liquid chromatography/mass spectrometry and group analogue internal standards. Chemosphere 57:1479-1488.
13. Metcalfe CD, Koenig BG, Bennie DT, Servos M, Ternes TA, Hirsch R. 2003. Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants. Environ Toxicol Chem 22:2872-2880.
14. Morland J, Olsen H. 1977. Metabolism of sulfadimidine. Sulfanilamide, para-aminobenzoic acid, and isoniazid in suspensions of parenchymal and non-parenchymal rat-liver cells. Drug Metab Dispos 5:511-517.
15. Suolinna EM. 1980. Metabolism of sulfanilamide and related drugs in isolated rat and rabbit liver-cells. Drug Metab Dispos 8:205-207.